DermBiont, Inc. — Form D
DermBiont, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-19. $2.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-19
- Form: D
- Accession: 0001779253-22-000002
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $2.5M
- Investors: 11
- Date of first sale: 2022-09-06
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-459201
Issuer
- Name: DermBiont, Inc.
- CIK: 0001779253
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 75 KNEELAND ST FL 14, BOSTON, MA, 02111
- Phone: 510-607-8155
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Steven R Basta | Director | Boston, MA |
| Karl R Beutner | Director | Boston, MA |
| Nichola R Eliovits | Director | Boston, MA |
| Jennifer R Lee | Director | Boston, MA |
| Wilder R Ramsey | Director | Boston, MA |
| Karl R Beutner | Executive Officer | Boston, MA |
| Max R Dawson | Executive Officer | Boston, MA |
| Nichola R Eliovits | Executive Officer | Boston, MA |
| Daniel R Yadegar | Director | Boston, MA |
| Ramsey R Wilder | Director | Boston, MA |
| Robert R Brucker | Executive Officer | Boston, MA |
Other filings by this issuer (11)
More